Wells Fargo Maintains Overweight on Doximity, Lowers Price Target to $45
Doximity, Inc. Class A +1.46%
Doximity, Inc. Class A DOCS | 24.25 | +1.46% |
Wells Fargo analyst Stan Berenshteyn maintains Doximity (NYSE:
DOCS) with a Overweight and lowers the price target from $55 to $45.
